Ann: Completion of Placement, page-299

Hi GC,

The distribution deals were not ready to go because potential distribution partners were not prepared to commit until FDA was achieved. The reason given from Lusia was they had zero appetite for risk.
The CEO and board were hoping to achieve FDA end 2016, and not in October. The reason for the delay the FDA had to create a new category for technology that actually interprets. we are the first and CEO and board had to wait for the FDA to ensure they were covered legally from there side before the approval was given.

As to new shareholders being pissed off at the current price, fair enough but they should blame themselves and not CEO and BOD, where have they failed to deliver short term? We achieved FDA approval , everyone got excited and jumped on board and pushed the price to $1.08 management didn't do this. The market did this, and the market has pushed the price down as they expected DD to be immediately signed which was totally naive and not what any long term holders have expected.

As to your comment on Lusia selling. She sold because she wanted/needed the money and felt the price was right to cash in a few shares. She sold no-where near the top and sold only 20% of her holding. Good on her. She hasn't bailed, she is still in the top 5 shareholders.

I make no short term price predictions, long term ie march 2017 believe we will hit new highs when distribution deal signed.

good luck all